Atlas Trials

A Study to Assess the Mass Balance of [14C] ABBV-552 in Healthy Male Participants Following Single Oral Dose Administration

Clinical trial NCT06278766 · COMPLETED

Trial details

NCT number
NCT06278766
Sponsor
AbbVie
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Healthy Volunteer
Start date
2024-02-21
Primary completion
2024-04-19
Enrollment
8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.